Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.

Falzone N, Ackerman NL, Rosales LF, Bernal MA, Liu X, Peeters SG, Soto MS, Corroyer-Dulmont A, Bernaudin M, Grimoin E, Touzani O, Sibson NR, Vallis KA.

Theranostics. 2018 Jan 1;8(1):292-303. doi: 10.7150/thno.22217. eCollection 2018.

2.

Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma.

Corroyer-Dulmont A, Falzone N, Kersemans V, Thompson J, Allen DP, Able S, Kartsonaki C, Malcolm J, Kinchesh P, Hill MA, Vojnovic B, Smart SC, Gaze MN, Vallis KA.

Radiother Oncol. 2017 Sep;124(3):488-495. doi: 10.1016/j.radonc.2017.05.002. Epub 2017 Jun 5.

3.

An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.

Kersemans V, Beech JS, Gilchrist S, Kinchesh P, Allen PD, Thompson J, Gomes AL, D'Costa Z, Bird L, Tullis IDC, Newman RG, Corroyer-Dulmont A, Falzone N, Azad A, Vallis KA, Sansom OJ, Muschel RJ, Vojnovic B, Hill MA, Fokas E, Smart SC.

PLoS One. 2017 Apr 28;12(4):e0176693. doi: 10.1371/journal.pone.0176693. eCollection 2017.

4.

Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.

Valable S, Corroyer-Dulmont A, Chakhoyan A, Durand L, Toutain J, Divoux D, Barré L, MacKenzie ET, Petit E, Bernaudin M, Touzani O, Barbier EL.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2584-2597. doi: 10.1177/0271678X16671965. Epub 2016 Jan 1.

5.

MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform.

Corroyer-Dulmont A, Falzone N, Kersemans V, Thompson J, Hill M, Allen PD, Beech J, Gilchrist S, Kinchesh P, Vojnovic B, Tullis I, Gaze MN, Smart S, Vallis KA.

Br J Radiol. 2017 Jan;90(1069):20160427. doi: 10.1259/bjr.20160427. Epub 2016 Sep 2.

6.

Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Chakhoyan A, Corroyer-Dulmont A, Leblond MM, Gérault A, Toutain J, Chazaviel L, Divoux D, Petit E, MacKenzie ET, Kauffmann F, Delcroix N, Bernaudin M, Touzani O, Valable S.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2270-2282. doi: 10.1177/0271678X16663947. Epub 2016 Jan 1.

7.

Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models.

Leblond MM, Gérault AN, Corroyer-Dulmont A, MacKenzie ET, Petit E, Bernaudin M, Valable S.

Oncoimmunology. 2015 Jun 5;5(1):e1056442. eCollection 2016.

8.

Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

Corroyer-Dulmont A, Pérès EA, Gérault AN, Savina A, Bouquet F, Divoux D, Toutain J, Ibazizène M, MacKenzie ET, Barré L, Bernaudin M, Petit E, Valable S.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):682-94. doi: 10.1007/s00259-015-3225-0. Epub 2015 Nov 5.

PMID:
26537287
9.

Imaging Modalities to Assess Oxygen Status in Glioblastoma.

Corroyer-Dulmont A, Chakhoyan A, Collet S, Durand L, MacKenzie ET, Petit E, Bernaudin M, Touzani O, Valable S.

Front Med (Lausanne). 2015 Aug 19;2:57. doi: 10.3389/fmed.2015.00057. eCollection 2015. Review.

10.

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.

Corroyer-Dulmont A, Pérès EA, Petit E, Durand L, Marteau L, Toutain J, Divoux D, Roussel S, MacKenzie ET, Barré L, Bernaudin M, Valable S.

Biol Chem. 2013 Apr;394(4):529-39. doi: 10.1515/hsz-2012-0318.

PMID:
23399636
11.

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Corroyer-Dulmont A, Pérès EA, Petit E, Guillamo JS, Varoqueaux N, Roussel S, Toutain J, Divoux D, MacKenzie ET, Delamare J, Ibazizène M, Lecocq M, Jacobs AH, Barré L, Bernaudin M, Valable S.

Neuro Oncol. 2013 Jan;15(1):41-56. doi: 10.1093/neuonc/nos260. Epub 2012 Oct 31.

12.

Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.

Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, Jonneaux A, Ballot C, Balayssac S, Valable S, Corroyer-Dulmont A, Bernaudin M, Malet-Martino M, de Lassalle EM, Maboudou P, Formstecher P, Polakowska R, Mortier L, Marchetti P.

Cancer Res. 2012 Oct 1;72(19):5035-47. doi: 10.1158/0008-5472.CAN-12-0979. Epub 2012 Aug 3.

Supplemental Content

Loading ...
Support Center